Development of a method to implement whole-genome bisulfite sequencing of cfDNA from cancer patients and a mouse tumor model

Elaine C. Maggi, Silvia Gravina, Haiying Cheng, Bilal Piperdi, Ziqiang Yuan, Xiao Dong, Steven K. Libutti, Jan Vijg, Cristina Montagna

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The goal of this study was to develop a method for whole genome cell-free DNA (cfDNA) methylation analysis in humans and mice with the ultimate goal to facilitate the identification of tumor derived DNA methylation changes in the blood. Plasma or serum from patients with pancreatic neuroendocrine tumors or lung cancer, and plasma from a murine model of pancreatic adenocarcinoma was used to develop a protocol for cfDNA isolation, library preparation and whole-genome bisulfite sequencing of ultra low quantities of cfDNA, including tumor-specific DNA. The protocol developed produced high quality libraries consistently generating a conversion rate > 98% that will be applicable for the analysis of human and mouse plasma or serum to detect tumor-derived changes in DNA methylation.

Original languageEnglish (US)
Article number6
JournalFrontiers in Genetics
Volume9
Issue numberJAN
DOIs
StatePublished - Jan 23 2018

Fingerprint

DNA Methylation
Genome
DNA
Neoplasms
Neuroendocrine Tumors
Serum
Gene Library
Libraries
Lung Neoplasms
Adenocarcinoma
hydrogen sulfite

Keywords

  • Biomarker
  • Cell-free DNA
  • CfDNA
  • Circulating DNA, mouse cfDNA
  • DNA methylation
  • Non-invasive blood based screening
  • Pancreatic cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Development of a method to implement whole-genome bisulfite sequencing of cfDNA from cancer patients and a mouse tumor model. / Maggi, Elaine C.; Gravina, Silvia; Cheng, Haiying; Piperdi, Bilal; Yuan, Ziqiang; Dong, Xiao; Libutti, Steven K.; Vijg, Jan; Montagna, Cristina.

In: Frontiers in Genetics, Vol. 9, No. JAN, 6, 23.01.2018.

Research output: Contribution to journalArticle

@article{8a2af04b236f441a82a918b5e264d7c3,
title = "Development of a method to implement whole-genome bisulfite sequencing of cfDNA from cancer patients and a mouse tumor model",
abstract = "The goal of this study was to develop a method for whole genome cell-free DNA (cfDNA) methylation analysis in humans and mice with the ultimate goal to facilitate the identification of tumor derived DNA methylation changes in the blood. Plasma or serum from patients with pancreatic neuroendocrine tumors or lung cancer, and plasma from a murine model of pancreatic adenocarcinoma was used to develop a protocol for cfDNA isolation, library preparation and whole-genome bisulfite sequencing of ultra low quantities of cfDNA, including tumor-specific DNA. The protocol developed produced high quality libraries consistently generating a conversion rate > 98{\%} that will be applicable for the analysis of human and mouse plasma or serum to detect tumor-derived changes in DNA methylation.",
keywords = "Biomarker, Cell-free DNA, CfDNA, Circulating DNA, mouse cfDNA, DNA methylation, Non-invasive blood based screening, Pancreatic cancer",
author = "Maggi, {Elaine C.} and Silvia Gravina and Haiying Cheng and Bilal Piperdi and Ziqiang Yuan and Xiao Dong and Libutti, {Steven K.} and Jan Vijg and Cristina Montagna",
year = "2018",
month = "1",
day = "23",
doi = "10.3389/fgene.2018.00006",
language = "English (US)",
volume = "9",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "JAN",

}

TY - JOUR

T1 - Development of a method to implement whole-genome bisulfite sequencing of cfDNA from cancer patients and a mouse tumor model

AU - Maggi, Elaine C.

AU - Gravina, Silvia

AU - Cheng, Haiying

AU - Piperdi, Bilal

AU - Yuan, Ziqiang

AU - Dong, Xiao

AU - Libutti, Steven K.

AU - Vijg, Jan

AU - Montagna, Cristina

PY - 2018/1/23

Y1 - 2018/1/23

N2 - The goal of this study was to develop a method for whole genome cell-free DNA (cfDNA) methylation analysis in humans and mice with the ultimate goal to facilitate the identification of tumor derived DNA methylation changes in the blood. Plasma or serum from patients with pancreatic neuroendocrine tumors or lung cancer, and plasma from a murine model of pancreatic adenocarcinoma was used to develop a protocol for cfDNA isolation, library preparation and whole-genome bisulfite sequencing of ultra low quantities of cfDNA, including tumor-specific DNA. The protocol developed produced high quality libraries consistently generating a conversion rate > 98% that will be applicable for the analysis of human and mouse plasma or serum to detect tumor-derived changes in DNA methylation.

AB - The goal of this study was to develop a method for whole genome cell-free DNA (cfDNA) methylation analysis in humans and mice with the ultimate goal to facilitate the identification of tumor derived DNA methylation changes in the blood. Plasma or serum from patients with pancreatic neuroendocrine tumors or lung cancer, and plasma from a murine model of pancreatic adenocarcinoma was used to develop a protocol for cfDNA isolation, library preparation and whole-genome bisulfite sequencing of ultra low quantities of cfDNA, including tumor-specific DNA. The protocol developed produced high quality libraries consistently generating a conversion rate > 98% that will be applicable for the analysis of human and mouse plasma or serum to detect tumor-derived changes in DNA methylation.

KW - Biomarker

KW - Cell-free DNA

KW - CfDNA

KW - Circulating DNA, mouse cfDNA

KW - DNA methylation

KW - Non-invasive blood based screening

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=85041307621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041307621&partnerID=8YFLogxK

U2 - 10.3389/fgene.2018.00006

DO - 10.3389/fgene.2018.00006

M3 - Article

AN - SCOPUS:85041307621

VL - 9

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - JAN

M1 - 6

ER -